Timothy S. Nelson
Chief Executive Officer, MAP Pharmaceuticals, Inc.
Companies
- Impel Neuropharma (United States)Board member Apr 22, 2021 to Apr 9, 20241
- SURMODICS INCBoard member Feb 19, 2014 to Dec 5, 20142
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Impel Neuropharma (United States)0 shares3Apr 5, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 5, 2024Other 10,000 shares of Impel Neuropharma (United States)3
- Nov 19, 2021Bought 10,000 shares at $10.76 of Impel Neuropharma (United States)4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARSURMODICS INC, Board member
- 3
- 4SEC EDGARForm 4 filed Nov 22, 2021